]i of 600 nM. Application of caveolin-3 antibody or caveolin-3 scaffolding domain peptide, corresponding to amino acid residues 55-74 of caveolin-3, also significantly slowed Ca 2ϩ removal rate at a measured [Ca 2ϩ ]i of 250 nM, with little effect at a measured [Ca 2ϩ ]i of 600 nM. Likewise, application of calmodulin inhibitory peptide, autocamtide-2-related inhibitory peptide, and cyclosporine A, inhibitors for calmodulin, Ca 2ϩ /calmodulin-dependent protein kinase II, and calcineurin, also significantly inhibited Ca 2ϩ removal rate at a measured [Ca 2ϩ ]i of 250 nM but not at 600 nM. Application of cyclopiazonic acid, a sarcoplasmic reticulum Ca 2ϩ ATPase inhibitor, also significantly inhibited Ca 2ϩ removal rate at a measured [Ca 2ϩ ]i of 250 nM but not at 600 nM. Our results suggest that caveolin-1 and caveolin-3 are important in Ca 2ϩ removal of resistance artery smooth muscle cells.
caveolin-1 scaffolding domain peptide; caveolin-3 scaffolding domain peptide; calmodulin; calcium/calmodulin-dependent protein kinase II; calcineurin CAVEOLAE ARE OMEGA-SHAPED plasmalemmal invaginations that occupy up to 20% of the total cell surface area in smooth muscle cells (6) (for review, see Ref. 34) . Lately, the importance of caveolae in cell signaling has become apparent. First, it has been shown that a variety of key proteins, including receptors and ion channels, are located within caveolae (34) . Apart from bringing receptors and effectors together into a confined microdomain, this topological arrangement may be useful because caveola invaginations also provide the shortest distance between the cell membrane and intracellular organelles (25) . Second, it has been shown that the signature proteins of caveolae, the caveolins (22, 35) , interact with a wide range of proteins involved in cell signaling (30, 34) . To date, three caveolin genes [caveolin-1 (Cav1), caveolin-2 (Cav2), and caveolin-3 (Cav3)] have been identified (30, 34) . Caveolins are the central component of caveolae, not only because they are required for caveola formation but also because they contain a 20-amino acid sequence, termed a scaffolding domain (24) , which plays a key role in regulating signal transduction cascades. It is now known that many, but not all, caveolin-interacting proteins contain motifs of ⌽X⌽XXXX⌽ or ⌽XXXX⌽XX⌽ (⌽ is an aromatic amino acid) recognizing caveolin scaffolding domains (6) . This relatively loose requirement on the part of partner proteins may partially explain the relative promiscuity of caveolins with a wide range of targets. Presently, it is understood that caveolin scaffolding domains act as docking sites to anchor various proteins within caveolae and regulate a variety of signaling molecules negatively or positively (5) .
The recent creation of Cav1 knockout mice has uncovered a multitude of roles played by Cav1 in vascular contractility (8, 32) . First, endothelium-dependent relaxation of aorta was potentiated in knockout mice. Second, contractile responses of small arteries to vasoconstrictors were significantly reduced. Third, the frequency of spontaneous transient outward currents (STOCs), an important determinant of myogenic tone of resistance arteries (29) (see also DISCUSSION) , was significantly lowered in cells from Cav1-null mice. In a separate study, it has been reported that aortae of Cav1-knockout mice showed an enhanced Ca 2ϩ response to endothelin-1 (15) . Moreover, chemical loading of Cav1 scaffolding domain peptide (Cav1 SDP, corresponding to Cav1 amino acids 82-101) into aorta significantly inhibited protein kinase C-mediated contraction (16) . These observations strongly indicate that Cav1 is important in regulating vascular tone. Furthermore, the hypothesis that Cav1 may be important in Ca 2ϩ homeostasis has been suggested based on the immunocytochemical finding that various Ca 2ϩ regulatory proteins were localized with Cav1 in esophageal sphincter (7) . Also, in nonsmooth muscle cells, Cav1 has been implicated in Ca 2ϩ homeostasis (12, 17) . However, to date, Ca 2ϩ handling processes that may be coordinated by Cav1 have not been examined in smooth muscle cells, including arterial smooth muscle cells. Furthermore, it has been shown that Cav3, a prominent caveolin isoform in the heart (39) , is also expressed in arterial vasculature (13 
MATERIALS AND METHODS
Cell isolation. Male Sprague-Dawley rats (200 -300 g) were made unconscious by exposure to a rising concentration of CO 2 and euthanized by exsanguination in accordance with Schedule 1 of the Animals (Scientific Procedure) Act (1986) under license from the Home Office, United Kingdom. All procedures involving animals were reviewed and approved locally by the University of Liverpool. We dissociated single smooth muscle cells from superior cerebral arteries (Ͻ200 m diameter) (19) by using a two-step enzymatic treatment (21) . The arteries were first digested for 25 min at 35°C with 1.7 mg/ml papain and 0.7 mg/ml dithioerythritol in a low-Ca 2ϩ solution containing (in mM) 134 NaCl, 5 KCl, 1 MgCl2, 0.1 CaCl2, 10 HEPES, 10 glucose, and 0.2 EDTA (pH adjusted to 7.3 at room temperature using NaOH). Next, the arteries were further digested for 20 min at 35°C with 1.7 mg/ml collagenase (type F) and 1 mg/ml hyaluronidase (type I-S) in the low-Ca 2ϩ solution. Single smooth muscle cells were obtained by triturating the arteries with a fire-polished Pasteur pipette.
Immunocytochemistry. Single smooth muscle cells were allowed to settle onto size 1 cover glasses and fixed with 2% paraformaldehyde in PBS containing (in mM) 2.7 KCl, 1.5 KH 2PO4, 137 NaCl, and 8 Na 2HPO4 (pH 7.4). Unreacted aldehyde was quenched with 100 mM glycine buffer (pH 7.4), and cells were permeabilized with 0.1% Triton X-100 in PBS. Mouse monoclonal primary antibodies against Cav1 (Cav1 Ab), Cav2 (Cav2 Ab), and Cav3 (Cav3 Ab) were diluted by 200-, 200-, and 500-fold, respectively, with antibody diluting solution. Antibody diluting solution was made with 2% goat serum, 1% BSA, and 0.05% Triton X-100 in sodium citrate buffer containing (in mM) 150 NaCl and 15 Na 3 citrate (pH 7.2). Primary antibodies were visualized with fluorescent anti-mouse secondary antibody (Alexa fluor 488) diluted 500-fold. To examine nonspecific binding of the secondary antibody, the control cells were treated with secondary antibody alone. We used a Leica (SP2 AOBS) confocal microscope to detect fluorescent signals.
Electrophysiology and microfluorometry. Simultaneous measurement of membrane current and Ca 2ϩ transient was performed as previously described (21) . A conventional whole cell clamp technique was used to record membrane currents. Whole cell membrane currents were amplified by an Axopatch 200B amplifier (Axon Instruments), filtered at 1 kHz, and sampled at 5 kHz using pCLAMP 7 (Axon Instruments). The cells were voltage clamped at Ϫ70 mV, and depolarization to 0 mV was applied for duration of 1.8 s to activate voltage-dependent Ca 2ϩ currents. The Ca 2ϩ -sensitive dye fura 2 was included in the pipette solution to report [Ca 2ϩ ]i. A single cell was alternately illuminated for 10 ms with UV light at 340 and 380 nm (bandpass 8 nm). Emission signals were obtained at 510 nm (bandpass 40 nm). Background fluorescence was measured for each cell after the formation of a gigaohm seal and subtracted from the measurements obtained during the experiments. The composition of extracellular solution was (in mM) 120 NaCl, 20 tetraethylammonium chloride, 1.1 MgCl2, 10 HEPES, 3 CaCl2, and 30 glucose (pH 7.4). The composition of intracellular solution was (in mM) 145 CsCl, 3 MgCl2, 3 Na2ATP, 10 HEPES, and 0.05 fura 2 pentapotassium salt (pH 7.2). In all experiments, including control experiments, cells were dialyzed with the pipette solutions for at least 10 min before commencement of measurements. Cav1 Ab (200-fold dilution), Cav1 SDP (10 M; residues corresponding to amino acids 82-101, DGIWKASFT-TFTVTKYWFYR), Cav3 Ab (500-fold dilution), Cav3 SDP (10 M; residues corresponding to amino acids 55-74, DGVWRVSYT-TFTVSKYWCYR), calmodulin inhibitory peptide (50 nM), and autocamtide-2-related inhibitory peptide (10 M) were applied by inclusion in the intracellular solution. Cyclosporine A (10 M) and cyclopiazonic acid (CPA; 10 M) were included in the extracellular solution. All agents except Cav1 Ab and Cav3 Ab were made as stock solutions using vehicles recommended by the manufactures and diluted at least 1,000-fold in the intracellular or extracellular solutions. All experiments were performed at room temperature. Detailed methods of Ca 2ϩ removal analysis are described elsewhere (20) . Statistics. Data are expressed as means Ϯ SE of n cells. The number of rats used is also mentioned in the text. When appropriate, one-way ANOVA, followed by Tukey's test as a post hoc analysis, was used to examine significant differences for multiple comparisons.
Drugs. Fura 2 pentapotassium salt and Alexa fluor 488 secondary antibody were obtained from Molecular Probes. Papain was purchased from Worthington Biochemical. Calmodulin inhibitory peptide, autocamtide-2-related inhibitory peptide, CPA, and cyclosporine A were obtained from Calbiochem. Cav1 Ab, Cav2 Ab, and Cav3 Ab were purchased from BD Transduction Laboratories. Cav1 SDP and Cav3 SDP were synthesized by Sigma Genosys. All other agents were purchased from Sigma or BDH.
RESULTS
Immunostaining of Cav1, Cav2, and Cav3 in cerebral artery smooth muscle cells. It has been previously reported that ferret aortic smooth muscle cells were positively stained with Cav1 Ab, as visualized by fluorescent probes (16) . Therefore, we first examined whether cerebral arterial smooth muscle cells also express Cav1. As shown in Fig. 1A , rat cerebral artery smooth muscle cells were stained positively with Cav1 Ab. When the cells were treated with the secondary antibody alone, virtually no signal was detected (Fig. 1D) . The staining pattern in our cells was very similar to that of ferret aortic smooth muscle cells (16) . Contrary to Cav1 staining, the visualization of Cav2 Ab produced a substantially dimmer image (Fig. 1B) , whereas that of Cav3 Ab was indistinguishable from that with Cav1 Ab (Fig. 1C) . Because Cav1 and Cav3 seemed prominently expressed in our cells, we sought to examine the possible involvement of these proteins in Ca 2ϩ homeostasis. Effect of Cav1 Ab and Cav1 SDP on Ca 2ϩ removal. The Ca 2ϩ handling patterns of rat cerebral resistance artery smooth muscle cells were previously reported (20) . However, it was necessary to perform control experiments with a condition matching our later experiments. Because the experiments designed to test the effect of antibodies and peptide blockers (see below) would require prolonged dialysis, we conducted the control experiments in the same condition. Thus the control cells were dialyzed with the control pipette solution for 10 min before the commencement of the measurements. Figure 2 shows an example of a control Ca 2ϩ transient ( Fig. 2A ) triggered by a depolarization to 0 mV from a holding potential of Ϫ70 mV (Fig. 2B ). channel antagonist nimodipine (19) and enhanced by the agonist BAY K 8644 (20 (20) . Also, by the end of a 1.8-s depolarization to 0 mV, Ca 2ϩ channels were largely inactivated due to Ca 2ϩ -and voltage-dependent inactivation, as seen by the lack of tail current (Fig. 2C, right) removal profile. Because the same arteries from the same strain of rats were used in both studies, this may be because of the prolonged dialysis in our experiments. Next, we examined how, if at all, the Ca 2ϩ removal profile may be modified by disruption of Cav1. In cardiac myocytes, it has been shown that the inclusion of Cav3 Ab abolished the isoproterenol-induced enhancement of Na ϩ current (40). Thus we hypothesized that application of the Cav1 Ab, which was effective in immunostaining in our cells, may functionally disrupt Cav1. Figure 3A shows one such experiment, in which Cav1 Ab was included in the pipette solution and dialyzed for 10 min. Ca 2ϩ transient recovery was slower in the presence of Cav1 Ab. As previously reported in cardiac myocytes, the mechanism by which caveolin antibody exerts its effect is unknown (10) . We therefore sought to determine whether the apparent change in Ca 2ϩ removal profile can be repeated by the application of Cav1 SDP. Figure 3B shows one such experiment. The Ca 2ϩ transient recovered slowly when the cell was dialyzed with 10 M Cav1 SDP. Thus two Cav1 inhibitory agents based on different principles, an immunoglobulin and a short peptide, produced similar results. Figure 3C summarizes Ca 2ϩ removal rate, expressed as a function of measured [Ca 2ϩ ] i at 25 nM intervals, for the control cells, Cav1 Abtreated cells, and Cav1 SDP-treated cells. Multiple statistical comparisons for these results, along with the results that will be described later, were carried out, and the outcome is also shown in the Fig. 3C Ab was introduced into the cell interior from the patch pipette, and Ca 2ϩ transients were examined after 10-min dialysis. Figure 4A shows one such experiment. In the presence of Cav3 Ab, the Ca 2ϩ transient recovery occurred more slowly. Thus we also investigated whether the apparent change in Ca 2ϩ removal profile can be replicated by the application of Cav3 SDP. Figure 4B shows one such experiment. Once again, the Ca 2ϩ transient recovered slowly when the cell was dialyzed with 10 M Cav3 SDP. Figure 4C (20) . Thus sarcoplasmic reticulum Ca 2ϩ uptake seems to be important at low [Ca 2ϩ ] i (20) . In the present study, application of CPA, another type of sarcoplasmic reticulum Ca 2ϩ uptake inhibitor, produced a similar result. As shown in Fig. 8A , in the presence of 10 M CPA, the Ca 2ϩ transient recovered slowly. Figure 8B summarizes ] i and is within the range that is physiologically important in these cells (26) (see also DISCUSSION). Ca 2ϩ removal rate was significantly different from control when the cells were treated with Cav1 Ab (P Ͻ 0.01), Cav1 SDP (P Ͻ 0.001), Cav3 Ab (P Ͻ 0.001), Cav3 SDP (P Ͻ 0.001), calmodulin inhibitory peptide (P Ͻ 0.001), autocamtide-2-related inhibitory peptide (P Ͻ 0.01), cyclosporine A (P Ͻ 0.001), and CPA (P Ͻ 0.05). Figure 9B summarizes ] i , no significant differences were detected among the various conditions. It is possible, however, that the higher noise level seen at higher [Ca 2ϩ ] i might have made the detection of significant differences among various treatments difficult; hence, further study will be required to fully conclude that the functional inhibition of caveolins and Ca 2ϩ -dependent enzymes do not modify Ca 2ϩ clearance when [Ca 2ϩ ] i is high. Nonetheless, significant differences were detected at lower [Ca 2ϩ ] i , and these results are consistent with the hypothesis that caveolin scaffolding domains act as part of a signal transduction complex for Ca 2ϩ -dependent enzymes to regulate Ca 2ϩ clearance. Furthermore, Ca 2ϩ removal was significantly affected by the blockade of Ca 2ϩ uptake to the sarcoplasmic reticulum over low [Ca 2ϩ ] i (Ref . 20 and this study) . The range of [Ca 2ϩ ] i where removal rates were affected is of importance (Figs. 4C and 9 ). It should be noted that the [Ca 2ϩ ] i range where Cav1 Ab, Cav1 SDP, Cav3 Ab, and Cav3 SDP were effective is important. Arterial smooth muscle cells do not normally fire action potentials but rather produce small and steady depolarizations. Under physiological conditions, cerebral resistance artery smooth muscle cells are unlikely to experience [Ca 2ϩ ] i elevation going much beyond 300 nM (26) . Ca 2ϩ removal rates over this concentration range were significantly modified by the inclusion of Cav1 Ab, Cav1 SDP, Cav3 Ab, and Cav3 SDP in the pipette solution (Figs. 3C  and 4C ). Thus our results indicate that Cav1 and Cav3 play an important role in Ca 2ϩ removal over physiologically relevant [Ca 2ϩ ] i . The importance of Ca 2ϩ -activated enzymes on Ca 2ϩ removal rate has been reported in nonarterial muscle cells (1, 27) , but equivalent studies in arterial smooth muscle cells are lacking. Thus, in the present study, we investigated the effect of Ca 2ϩ -dependent enzyme inhibitors on the Ca 2ϩ clearance profile in our cells. We report that application of calmodulin inhibitory peptide significantly slowed the Ca 2ϩ removal rate over low to medium [Ca 2ϩ ] i with little effect at higher [Ca 2ϩ ] i (Figs. 5B and 9 ). Calmodulin is a ubiquitous Ca 2ϩ -binding protein and exerts its effects directly and indirectly on various proteins, including ryanodine-sensitive Ca 2ϩ -releasing channels (2) and sarcoplasmic reticulum Ca 2ϩ pumps (38) . It has been reported that calmodulin may be regulated by Cav1 in nonsmooth muscle cells. In cultured endothelial cells and Sf-9 cells, it has been noted that Cav1 and calmodulin reciprocally regulate endothelial nitric oxide synthase (28) . Crucially, the scaffolding domain of Cav1 seems important in endothelial nitric oxide synthase regulation, although it may not interact with calmodulin directly (28) . This is a very complex issue to address, however, because calmodulin does not necessarily regulate the final target molecules directly but may exert its effect by regulating other Ca 2ϩ -dependent enzymes such as CaMKII and calcineurin. Nonetheless, the results presented here provide an interesting insight to the regulation of Ca 2ϩ homeostasis by these enzymes.
In cardiac myocytes, it has been reported that CaMKII is important in facilitating Ca 2ϩ sequestration to the sarcoplasmic reticulum (1) . The role of CaMKII was ascribed to the phosphorylation of phospholamban, a small protein that tonically inhibits the sarcoplasmic reticulum Ca 2ϩ pump (Ref. 38 , but also see Ref. 23) . When phosphorylated, phospholamban dissociates from the sarcoplasmic reticulum Ca 2ϩ pump, increasing its activity (38) . CaMKII has also been implicated in Ca 2ϩ -dependent acceleration of Ca 2ϩ removal in toad gastric myocytes, although in this instance the target organelle is mitochondria (27) . However, a comparable study that used peptide inhibitors to examine the role of CaMKII is yet to be carried out in arterial smooth muscle cells. We report that application of autocamtide-2-related inhibitory peptide significantly slowed the Ca 2ϩ removal rate up to [Ca 2ϩ ] i of 250 nM with little effect at higher [Ca 2ϩ ] i (Figs. 6B and 9). Our results are in agreement with those of cardiac myocytes, in which CaMKII was found to be important in facilitating Ca 2ϩ sequestration to the sarcoplasmic reticulum (1). However, it should also be noted that CaMKII does not interact with caveolin in the signal transduction pathway involved in KCl-induced contraction in ferret aorta (16) . Furthermore, as discussed above, CaMKII may also be regulated by other enzymes such as calmodulin, and thus further work will be needed to fully dissect complex interaction among these enzymes.
As described earlier, the role of Ca 2ϩ -dependent protein kinases in Ca 2ϩ removal has been examined and identified in nonarterial muscle cells (1, 27) . However, the involvement of phophatases in Ca 2ϩ clearance was not studied in these early works, although it has been suggested that calcineurin, a ubiquitous protein phosphatase, inhibits Ca 2ϩ uptake to the sarcoplasmic reticulum in cardiac myocytes (36 (Figs. 7B and 9) . These results offer further insight to the signal transduction cascade that is important in Ca 2ϩ clearance in arterial smooth muscle cells. The question of whether calcineurin directly affects the proteins responsible for Ca 2ϩ removal, or requires additional second messengers, could be addressed by biochemical investigation in the future.
The results described above provide evidence that inhibition of calmodulin, CaMKII, and calcineurin significantly reduced Ca 2ϩ removal rates to various degrees in rat superior artery smooth muscle cells (Fig. 9A) . Whether the action of these enzymes is coordinated by Cav1 and/or Cav3 through their scaffolding domains needs to be investigated in the future. It is plausible that, given the long list of proteins that are regulated by caveolins, at least some of these Ca 2ϩ -activated enzymes are coordinated by caveolins. One interesting hypothesis is that calcineurin may be colocalized with Cav1, since Cav1 and protein kinase A are colocalized (33), whereas calcineurin seems to be colocalized with protein kinase A (36) and protein kinase A-anchoring protein (31) . It should be also noted that, in nonsmooth muscle cells, calmodulin may be regulated by Cav1, although calmodulin may not interact directly with the scaffolding domain (28) .
As reported previously (20) , the Ca 2ϩ removal rate was suppressed when cells were treated with CPA (Fig. 8B ). It has also been shown in these cells that Ca 2ϩ clearance through Na ϩ /Ca 2ϩ exchange is not important, whereas that through the plasmalemmal Ca 2ϩ pump plays a minor role at low [Ca 2ϩ ] i (20) . Because the functional inhibition of caveolins also affected Ca 2ϩ removal over a low to medium [Ca 2ϩ ] i range, it is possible that Ca 2ϩ uptake to the sarcoplasmic reticulum could be regulated by caveolins. If indeed this is the case, it would have an important implication regarding the regulation of vascular contractility. In arterial smooth muscle cells from Cav1-knockout mice, it has been reported that the frequency of STOCs, caused by the opening of multiple Ca 2ϩ -dependent K channels (29) , was reduced (8) . STOCs are a crucial determinant of artery membrane potential (29) , and understanding of STOC inhibition in Cav1-null cells will help with the elucidation of vascular tone regulation. The sequence of events that inhibit STOC frequency in Cav1-knockout mice is hypothesized as follows. The loss of caveolae results in increased distance between caveolemmal voltage-dependent Ca 2ϩ channels and ryanodine-sensitive Ca 2ϩ -releasing channels in the sarcoplasmic reticulum (25) . In this modified geometry, the occurrence of Ca 2ϩ sparks, synchronized Ca 2ϩ release from clusters of ryanodine-sensitive channels (29) , will be reduced because elevation of Ca 2ϩ in the subsarcolemmal domain, the activator of ryanodine-sensitive channels, will be smaller. The reduced frequency of Ca 2ϩ sparks will lead to compromised STOCs because Ca 2ϩ sparks trigger STOCs (25, 29) . This hypothesis neatly explains the observed inhibition of STOC frequency in Cav1-null cells. However, if the absence of Cav1 also reduces Ca 2ϩ content of the sarcoplasmic reticulum as a result of reduced Ca 2ϩ sequestration to this organelle, the open probability of ryanodine-sensitive channels may be inhibited because these channels are regulated by the luminal Ca 2ϩ content (14) . Although it has been reported that the Ca 2ϩ content of the sarcoplasmic reticulum was unchanged in cells that are made caveola-free with methyl-␤-cyclodextrin, a cholesterol-depleting agent, subtle changes may be difficult to detect with the methods used (25) . Thus our finding may provide an additional explanation of why STOC frequency is inhibited in cells from Cav1-null mice. This hypothesis is consistent with the report that the frequency, amplitude, and width of Ca 2ϩ sparks were reduced in cells treated with methyl-␤-cyclodextrin (Ref. 25 , but also see Ref. 4) . However, the identification of target molecules for caveolins would be complicated. Obviously, block of the sarcoplasmic reticulum Ca 2ϩ pump, as seen with thapsigargin (20) or CPA (this study), would inhibit Ca 2ϩ sequestration to this organelle. However, there are other possibilities. For example, if functional inhibition of caveolins locks ryanodine-sensitive Ca 2ϩ -releasing channels to the semiconducting state (11), Ca 2ϩ sequestration to this organelle will be effectively blocked due to a "leaky" sarcoplasmic reticulum (20) . Testing of various possible mechanisms is rather difficult, partly because regulation of sarcoplasmic reticulum Ca 2ϩ pumps and Ca 2ϩ -releasing channels are yet to be fully elucidated (11, 38) . Furthermore, the exact role of Ca 2ϩ -activated enzymes and their target molecules have not been fully understood. For example, a clear consensus regarding the role of calcineurin on various Ca 2ϩ -handling pathways has not been reached (9, 36, 37) . Nonetheless, the results presented here offer new information regarding Ca 2ϩ clearance mechanisms of arterial smooth muscle cells.
In conclusion, we have shown the evidence that Cav1 and Cav3 regulate Ca 2ϩ homeostasis in rat cerebral resistance artery smooth muscle cells. These findings support the idea that caveolins serve an important function in the regulation of vascular contractility. Starting from left, columns show the results from control cells (n ϭ 8 from 5 rats) and cells treated with Cav1 Ab (n ϭ 6 from 4 rats; P Ͻ 0.01), Cav1 SDP (n ϭ 10 from 7 rats; P Ͻ 0.001), Cav3 Ab (n ϭ 13 from 10 rats; P Ͻ 0.001), Cav3 SDP (n ϭ 10 from 7 rats; P Ͻ 0.001), CIP (n ϭ 9 from 6 rats; P Ͻ 0.001), A-2 RIP (n ϭ 14 from 8 rats; P Ͻ 0.01), cyclosporine A (cyclo A, n ϭ 9 from 8 rats; P Ͻ 0.001), and CPA (n ϭ 6 from 5 rats; P Ͻ 0.05). B: Ca 2ϩ removal rate determined at a [Ca 2ϩ ]i of 600 nM. At this higher [Ca 2ϩ ]i, no significant differences were detected among various conditions.
